MERS-CoVs were detected in specimens using real-time reverse transcription (rRT)-PCR. Extracted RNAs were screened by targeting the upE region, and positive results were confirmed by a subsequent amplification of orf1a using a PowerChek MERS Real-Time PCR kit (Kogene Biotech, Seoul, South Korea). All rRT-PCR reactions were performed using the 7500 Fast Real-Time PCR System (Applied Biosystems) with a total reaction volume of 20 μL (15 μL of PCR reaction mixture and 5 μL of template RNA). The thermocycling conditions included a reverse transcription reaction for 30 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 sec at 95°C and 60 sec at 60°C. A positive viral template control and a nontemplate control were included in each run. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified simultaneously as an internal control to monitor PCR inhibition. A positive result was identified by a well-defined exponential fluorescence curve that crossed the defined threshold at ≤35 cycles in both the upE and ORF1a assays.
Qiaamp dsp viral rna mini kit
The QIAamp DSP Viral RNA Mini Kit is a laboratory equipment designed for the extraction and purification of viral RNA from various sample types. It utilizes a silica-based membrane technology to efficiently capture and elute viral RNA for downstream analysis.
Lab products found in correlation
9 protocols using qiaamp dsp viral rna mini kit
MERS-CoV Detection by rRT-PCR
MERS-CoVs were detected in specimens using real-time reverse transcription (rRT)-PCR. Extracted RNAs were screened by targeting the upE region, and positive results were confirmed by a subsequent amplification of orf1a using a PowerChek MERS Real-Time PCR kit (Kogene Biotech, Seoul, South Korea). All rRT-PCR reactions were performed using the 7500 Fast Real-Time PCR System (Applied Biosystems) with a total reaction volume of 20 μL (15 μL of PCR reaction mixture and 5 μL of template RNA). The thermocycling conditions included a reverse transcription reaction for 30 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 sec at 95°C and 60 sec at 60°C. A positive viral template control and a nontemplate control were included in each run. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified simultaneously as an internal control to monitor PCR inhibition. A positive result was identified by a well-defined exponential fluorescence curve that crossed the defined threshold at ≤35 cycles in both the upE and ORF1a assays.
Autonomous Lab-on-Paper for Multiplex-Gene Detection
SARS-CoV-2 Detection by Kaira Assay
MERS Clinical Specimen Collection
Total nucleic acid was extracted by using the QIAamp DSP Viral RNA Mini kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. A total of 140 µL of specimen was used, and the RNA was eluted in 50 µL and stored at −70℃ until testing with the PowerChek MERS and sequencing assays.
Norovirus Detection Cross-Reactivity Assay
RNA Extraction and RT-qPCR for SARS-CoV-2 Detection
SARS-CoV-2 Detection by rRT-PCR
COVID-19 Diagnostic Testing Protocol
samples were provided by the U2 Clinical Laboratories (Jangwon Medical
Foundation). The viral RNA of the COVID-19 disease was extracted and
purified by using the QIAamp DSP Viral RNA Mini Kit (QIAGEN). The
conventional RT-qPCR tests targeting the E gene, open reading frame
1 (ORF1) gene, and internal control (ribonuclease P; RNaseP) were
performed with a STANDARD M nCoV real-time detection kit (SD Biosensor)
for clinical diagnosis of COVID-19, and the remaining samples were
collected for the clinical diagnostic test of the pRT-qPCR system.
The patient samples and healthy controls are given identification
numbers after a random arrangement and delivered under single-blind
condition. The pRT-qPCR system performed E-gene-targeted clinical
diagnostic tests and internal control on each PoM cartridge.
SARS-CoV-2 Detection by One-Step RT-qPCR
Analysis of data was primarily descriptive.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!